The market for this critical component is surging. Roots Analysis values it at USD 8.3 billion in 2024, growing to USD 8.98 billion by 2025, and projected to reach USD 17.49 billion by 2035, with a 6.9% CAGR. That’s fueled by demand from cell therapies, mRNA, and more.